Investor presentations

Cowen 41st Annual Health Care Conference - presentation

March 3, 2021

Oncopeptides' CEO Marty J Duvall presented at the Cowen 41st Annual Health Care Conference, March 3, 2021, at 17.00 CET. The presenation is webcasted, see link below.

Read more

Company Presentation March 2021

March 3, 2021

New Company Presentation for Oncopeptides, March 2021.

Read more

FDA approval of PEPAXTO - Webcast for investors, analysts and the media

February 26, 2021

In conjunction with the FDA approval of PEPAXTO, Oncopeptides hosted a webcast March 1, 2021, at 07:30 (CET), including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, CMO Klaas Bakker, and C...

Read more

Webcast Year-end Report 2020 presentation

February 18, 2021

Oncopeptides held a webcast February 18, 2021 at 14:00 (CET) when the Year-end Report 2020 and an operational update was presented by CEO Marty J Duvall, CMO Klaas Bakker and CFO Anders Martin-Löf.

Read more

Oncopeptides Virtual Capital Markets Day

November 30, 2020

“Building a Fully Integrated Biotechnology Company”

Read more

Jefferies London Health Care Conference presentation

November 18, 2020

Marty J Duvall presents at Jefferies London Health Care Conference, Wednesday December 18, 2020. The webcast is recorded. See presentation and link below.

Read more

DNB investor presentation

November 9, 2020

Read more

Citi’s 15th Annual BioPharma Virtual Conference – Presentation

September 10, 2020

Oncopeptides' CEO Marty J Duvall and CSO Jakob Lindberg presented at Citi’s 15th Annual BioPharma Virtual Conference. Please see attached presentation below.

Read more

Pareto Securities 11:e Healthcare Conference – Presentation

September 2, 2020

Oncopeptides' CEO Marty J Duvall and CSO Jakob Lindberg presented at Pareto Securities Healthcare Conference. Please see attached presentation.

Read more

Webcast regarding operational update Q2 2020

August 26, 2020

Oncopeptides held an operational update Wednesday August 26, 2020. It was presented by CEO Marty J Duvall, CSO Jakob Lindberg and CFO Anders Martin-Löf. The presentation was also recorded, see link be...

Read more

Nordea Small Cap Seminar – Presentation

August 12, 2020

Oncopeptides presented at Nordea Small Cap Seminar on Aug 12, 2020. See presentation below.

Read more

Jefferies Healthcare Conference June 3, 2020

June 3, 2020

Oncopeptides CEO presents at 1.30 – 1.55 PM (EDT) (19.30-19.55 CEST). See attached presentation, and click the link below to come to the webinar.

Read more

Webcast regarding operational update Q1 2020

May 26, 2020

Oncopeptides held an operational update Tuesday May 26, 2020. It was presented by CEO Jakob Lindberg and members of Oncopeptides management team. The presentation was recorded, see link below.

Read more

Company Presentation April May 2020

April 27, 2020

Read more

Company Presentation March April 2020

March 31, 2020

Read more

Stockholm Corporate Finance Life Science Day – presentation

March 11, 2020

Oncopeptides’ CFO Anders Martin-Löf presented at the Stockholm Corporate Finance Life Science Day, March 11, 2020. See the recording of the presentation, and the presentation below.

Read more

Webcast Year-End Report 2019

February 20, 2020

Read more

Presentation at SEB Annual Pharma & Biotech Seminar 2020

January 22, 2020

Read more

2020 J.P. Morgan Health Care Conference – Presentation

January 21, 2020

San Francisco, 13-16 January 2020

Read more

Avanza Lunch Presentation

November 27, 2019

Oncopeptides’ CEO Jakob Lindberg presented at the Avanza Lunch meeting.

Read more

Investing in Oncology Forum 2019

October 7, 2019

Oncopeptides’ CFO Anders Martin-Löf held a presentation at Investing in Oncology Forum 2019 in Stockholm, Sweden, on October 7.

Read more

Corporate Presentation, 3 October 2019

October 3, 2019

Read more

Pareto Health Care Conference 2019

September 5, 2019

Oncopeptides AB (publ) presented at the Pareto Securities Health Care Conference 2019. See attached presentation.

Read more

Corporate Presentation, 17 June 2019

June 17, 2019

Read more

REDEYE Growth Day – Presentation

June 10, 2019

Oncopeptides CFO Anders Martin-Löf held a presentation at the REDEYE Growth Day, 10 June 2019. The Presentation was recorded and can be showed at the link below.

Read more

Jefferies 2019 Healthcare Conference, New York – Presentation

June 5, 2019

Oncopeptides CEO Jakob Lindberg gave a presentation at Jefferies Healthcare Conference in New York June 7, at 17.30 CET. The presentation was webcasted, see link below. You can also listen to the pres...

Read more

REDEYE Pre-ASCO Seminar – presentation

May 28, 2019

CEO Jakob Lindberg presented at the REDEYE Pre-ASCO Seminar, Tuesday May 28, in Stockholm, Sweden. See link to the recording of the presentation below.

Read more

Webcast regarding operational update

May 21, 2019

Oncopeptides held an operational update on Tuesday, May 21, 2019, at. 10:00 (CET). It was presented by CEO Jakob Lindberg and members of the Oncopeptides management team. The webcast was recorded. See...

Read more

Webcast regarding clinical program update

April 24, 2019

Oncopeptides held an webcast April 24, 2019, where CEO Jakob Lindberg provided new guidance on the patient recruitment in the OCEAN study and a clinical program update. The webcast was recorded. See t...

Read more

Kempen Life Science Conference 2019 – presentation

April 16, 2019

Oncopeptides presented at the Kempen Life Science Conference 2019 in Amsterdam, Netherlands.

Read more

Cowen & Company 39th Annual Health Care Conference – Presentation

March 11, 2019

CEO Jakob Lindberg presented at Cowen and Company 39th Annual Health Care Conference on March 11, 2019. The presentation was webbcasted, see link below.

Read more

Carnegie Healthcare Conference 2019 – presentation

March 6, 2019

CEO Jakob Lindberg presented at Carnegie Healthcare Conference, on March 6 2019.

Read more

Webcast Year-End Report 2018

February 22, 2019

The Year-end Report for 2018 and an operational update was presented by CEO Jakob Lindberg and members of Oncopeptides management team, February 22, 2019 at 14:00 (CET).

Read more

SEB Biotech Seminar – presentation

January 24, 2019

By Jakob Lindberg, CEO, Oncopeptides AB (publ).

Read more

2019 J.P. Morgan Health Care Conference – Presentation

January 16, 2019

San Francisco, January 7-10, 2019.

Read more

Oncopeptides Capital Markets Day in New York – presentations

December 14, 2018

Oncopeptides did host a Capital Markets Day on December 14th between 8.30-11.00 AM ET in New York, here is the presentation from the whole day. Speakers were Jakob Lindberg, Chief Executive Officer, o...

Read more

DNB Nordic Healthcare Conference 2018 – presentation

December 13, 2018

December 12, CEO Jacob Lindberg held a presentation at the DNB Nordic Healthcare Conference 2018 in Oslo.

Read more

Jakob Lindberg, CEO, Oncopeptides – Company presentation post ASH

December 6, 2018

Jakob Lindberg, CEO, Oncopeptides – Company presentation post ASH 2018.

Read more

Jefferies 2018 London Healthcare conference – Presentation & webcast

November 14, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies 2018 Healthcare conference in London November 14. The presentation was also recorded. Click on the recording (mp3-file) to view the Web...

Read more

Lunch presentation at DNB

September 25, 2018

Corporate presentation by Jakob Lindberg, CEO, Oncopeptides AB (publ), at DNB 25 September 2018.

Read more

Jefferies Health Care conference, New York – Presentation

June 7, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies Healthcare Conference in New York June 7.

Read more

Jakob Lindberg, CEO, is interviewed in Di tv

May 17, 2018

Read more

Carnegie Healthcare Seminar 2018 – presentation

March 14, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Carnegie Healthcare Seminar on March 14.

Read more

SCF Life Science Seminarium – presentation

March 7, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Stockholm Corporate Finance Live Science Seminarium March 7.

Read more

ABGSC Orphan Drug Day 2018 – Presentation

February 22, 2018

Oncopeptides presentation at the ABG Office in Stockholm, Sweden.

Read more

Jakob Lindberg interviewed in DI Börsmorgon

January 25, 2018

Oncopeptides CEO Jakob Lindberg is being interviewed in DI Börsmorgon, January 25, 2018.

Read more

JP Morgan, San Francisco – Presentation

January 12, 2018

January 8-10, 2018.

Read more

DNB Nordic Healthcare Conference 2017 – Oslo

December 14, 2017

Oncopeptides’ presentation at DNB in Oslo, 14 December.

Read more

Carnegie Healthcare Day in New York – presentation

December 6, 2017

Oncopeptides presentation at Carnegie, New York, 5 December 2017.

Read more

Lunch at ABG – presentation

November 15, 2017

Presentation at ABG.

Read more

Pareto Securities Healthcare conference 2017 – Presentation

September 7, 2017

Read more

Annual General Meeting 2017 – Presentation

May 18, 2017

Read more

DNB SME Conference 2017

April 5, 2017

Read more

Carnegie Health Care Seminar

March 16, 2017

Read more

Redeye – Fight cancer-event

March 10, 2017

Read more

Press release -

FDA approves Oncopeptides' PEPAXTO® ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma

Read press release
Events Oncopeptides

Upcoming events

View calendar

Oncopeptides via e-mail

Get our latest updates straight to your inbox. Unsubscribe at anytime.

This site is protected by reCAPTCHA & the Google Privacy Policy & Terms of Service  apply.